RNA interference and nanomedicine join forces to fight dangerous fungal infections
Fungal infections are on the rise globally. According to a study by the Manchester Fungal Infection Group, in 2022, ...
S’pore launches $130m RNA research programme to tackle wider range of ailments
The Republic aims to strengthen its RNA capabilities by providing a platform for key institutions here to collaborate. Read ...
First Ascent Biomedical, which uses AI to treat cancer, to create lab at Gannon University
Gannon University and Saint Vincent Hospital announced plans Wednesday to develop two new laboratories inside Gannon's ...
Nutcracker Therapeutics CEO Dr. Igor Khandros Retires as Company Continues Evolution as an RNA Therapeutics CRDMO
Dr. Khandros will remain on the board of directors of Nutcracker Therapeutics, and Cynthia Collins will serve as executive ...
FDA approves new drug to treat protein buildup in the heart
The FDA has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra ...
Primrose Bio Launches Prima RNApols™ ExTend, an RNA Polymerase for Long-Template mRNA Manufacturing
Primrose Bio, Inc. ("Primrose"), a company developing proprietary therapeutic manufacturing technologies, announces the ...
Nature1d
New antibiotic that kills drug-resistant bacteria discovered in technician’s garden
The molecule was found in soil samples collected from a laboratory technician’s garden. The discovery shows that “there is ...
Q&A: Nobel Prize-winning researcher and BU grad discusses vaccine development, vaccine hesitancy, and preparing for another pandemic
Weissman was jointly awarded the 2023 Nobel Prize in Medicine with Katalin Karikó for discoveries which made COVID-19 ...
Carlsbad’s Ionis strikes deal with Japanese pharma worth up to $940M
Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine targeting a chronic blood disorder.